Libido imbroglio

“Pro-sex feminist” speaks out against FDA approval of “female viagra”

Christopher Furlong/Getty Images

In an Op-Ed for The Washington Post, Cindy Pearson, the executive director for the National Women’s Health Network, spoke out against flibanserin, the so-called “female viagra” that a panel of experts recommended for FDA approval last week. Pearson says the FDA’s previous two rejections of flibanserin has had nothing to do with sexism, as many critics allege, and everything to do with due diligence. Her concern is that the little pink pill simply isn’t effective and doesn’t deserve to be on pharmacy shelves. “For some feminist groups and legislators, this due diligence is evidence of sexism in the FDA. They note that there are numerous approved treatments for male sexual dysfunction and low testosterone, but none for the most common form of sexual dysfunction in women,” she wrote in the Op-Ed. Pearson contends the sexist rhetoric surrounding flibanserin’s fate is “dangerous” and possibly influenced the panel’s decision to recommend the drug for approval. Pearson goes on to say that the hype about sexism within the FDA is in danger of distracting decision-makers from being appropriately “cautious about new drug treatments marketed for women’s health.”

Read the full story at The Washington Post.

Leave a Reply

Your email address will not be published. Required fields are marked *